Luciana Basili Dias Candidíase vulvovaginal em pacientes gestantes

Referências Bibliográficas 95
Millon L, Manteaux A, Reboux G, Drobacheff C, Monod M, Barale T, et al. Fluconazoleresistant
recurrent oral candidiasis in human immunodeficiency virus-positive patients:
persistence of Candida albicans strains with the same genotype. J Clin Microbiol. 1994; 32:
1115-8.
Moreira D, Paula CR. Vulvovaginal Candidiasis. Int J Gynaecol and Obstet. 2006; 92: 266-7.
Murray JS. Standardization of antifungal susceptibility testing. Resident e Staff Physician; 1991.
p. 26-9.
Namkinga LA, Matee MIN, Kivaisi K, Kullava A, Mneney EE. Identification of Candida strains
isolated from Tanzanian pregnant women with vaginal candidiais. East African Medical Journal.
2005; 82 (5): 226-34.
NCCLS – National Committee for Clinical Laboratory Standards, Reference method for broth
dilution antifungal susceptibility testing of yeast. Aproved Standard M27-A. Pennsylvania;1997.
NCCLS – National Committee for Clinical Laboratory Standards, Reference method for broth
dilution antifungal susceptibility testing of yeast. Aproved Standard M27-A2. 2ª ed. Wayne,
Pennsylvania; 2002.
Negroni R, Arechavala AI. Itraconazole: pharmacokinetics and indications. Arch. Med. Res.
1993; 24: 387-93.
Odds FC. Candida and Candidosis. 2ª ed. London: Bailliere Trindall; 1988a.
Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presuntive
identification of clinically important Candida species. J Clin Microbiol. 1994; 32: 1923-9.
Pádua RAF, Guihlermetti E, Svidzinski ETI. In vitro activity of antifungal agents on ueasts
isolates from vaginal secretion. Acta Scientiarum. Health Sciences. 2003; 25: 51-4.